Skip to main content
Premium Trial:

Request an Annual Quote

Ambion and Cenix to Develop Genome-Wide siRNA Library

NEW YORK, March 24 - Ambion and Cenix BioScience are partnering to co-develop and commercialize a library of short interfering RNA (siRNA) for the entire human genome, the companies said today.

 

Cenix, a spin-out from the European Molecular Biology Laboratory and the Max Planck Institute of Molecular Cell Biology and Genetics, will design siRNA reagents to enable high-throughput genome-wide screening in human cells, while Ambion will manufacture and market the reagents. The companies plan on updating the siRNA library in step with human genome sequence annotations.

 

The library is expected to be on the market in the middle of 2003.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.